Left bundle branch pacing as an alternative to biventricular pacing for cardiac resynchronisation therapy.

Autor: Rademakers LM; Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands. nard.rademakers@catharinaziekenhuis.nl., van den Broek JLPM; Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands., Bracke FA; Department of Cardiology, Catharina Hospital, Eindhoven, The Netherlands.
Jazyk: angličtina
Zdroj: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation [Neth Heart J] 2023 Apr; Vol. 31 (4), pp. 140-149. Date of Electronic Publication: 2022 Aug 03.
DOI: 10.1007/s12471-022-01712-9
Abstrakt: Background: Left bundle branch pacing (LBBP) is a novel physiological pacing technique which may serve as an alternative to biventricular pacing (BVP) for the delivery of cardiac resynchronisation therapy (CRT). This study assessed the feasibility and outcomes of LBBP in comparison to BVP.
Methods: LBBP was attempted in 40 consecutive patients as the first-line method for delivering CRT. To evaluate LBBP versus BVP, 40 patients with identical inclusion criteria who received BVP were compared with the LBBP group. Acute success rate, complications, functional and echocardiographic outcomes as well as hospitalisation for heart failure and all-cause mortality 6 months after implantation were evaluated.
Results: LBBP was successfully performed in 31 (78%) patients and resulted in significant QRS narrowing (from 166 ± 16 to 123 ± 18 ms, p < 0.001), improvement in left ventricular ejection fraction (LVEF; from 28 ± 8 to 43 ± 12%, p < 0.001) and New York Heart Association functional class (from 2.8 ± 0.5 to 1.6 ± 0.6, p < 0.001) at 6 months. No LBBP-related complications occurred. Compared to BVP, LBBP resulted in a greater reduction in QRS duration (44 ± 17 vs 15 ± 26 ms, p < 0.001) with comparable absolute improvement in LVEF (15.2 ± 11.7 vs 9.6 ± 12.1%, p = 0.088). Hospitalisation for heart failure and all-cause mortality were similar in the two groups.
Conclusions: LBBP is feasible and was safe in 78% of patients with favourable electrical resynchronisation and functional improvement and may serve as an alternative to BVP.
(© 2022. The Author(s).)
Databáze: MEDLINE
Externí odkaz: